FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Alan Schiffer

Research Profile

Disorders

Procedures

Chemicals & Drugs

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Felicetto Ferrara; Charles Alan Schiffer
Acute myeloid leukaemia in adults.
Farhad Ravandi; Charles Alan Schiffer; Richard A Larson; Francesco Lo Coco; Frederick R Appelbaum; Alan K Burnett; Elihu H Estey; Hagop M Kantarjian
Gemtuzumab ozogamicin: time to resurrect?
Charles Alan Schiffer
Which TKI should be recommended as initial treatment for CML in chronic phase?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Alan Schiffer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Felicetto Ferrara; Charles Alan Schiffer
Acute myeloid leukaemia in adults.
Lancet 2013;381(9865):484-95.
2012: Farhad Ravandi; Charles Alan Schiffer; Richard A Larson; Francesco Lo Coco; Frederick R Appelbaum; Alan K Burnett; Elihu H Estey; Hagop M Kantarjian
Gemtuzumab ozogamicin: time to resurrect?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(32):3921-3.
2012: Charles Alan Schiffer
Which TKI should be recommended as initial treatment for CML in chronic phase?
Oncology (Williston Park, N.Y.) 2012;26(10):912, 914.
2012: Richard M Stone; J Cortes; D J DeAngelo; A del Corral; C Dutreix; Gerhard Ehninger; T Fischer; A Huntsman-Labed; H M Kantarjian; R Paquette; Charles Alan Schiffer; G Schiller; F Giles
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.
Leukemia 2012;26(9):2061-8.
2012: Jay Yang; Charles Alan Schiffer
Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?
Expert review of hematology 2012;5(4):395-407.
2012: Roland B Walter; Frederick R Appelbaum; Bruno C Medeiros; Bayard L Powell; Charles Alan Schiffer; Elihu H Estey
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia.
Haematologica 2012;97(5):739-42.
2011: Agnieszka Vay; Sanjeev Kumar; Adnan R Munkarah; Charles Alan Schiffer; Assaad Semaan; Shelly Seward; Robert Thomas Morris
Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Gynecologic oncology 2011;123(3):456-60.
2011: Charles Alan Schiffer
What to do if there is no evidence? The issue of surgical procedures in patients with thrombocytopenia.
Transfusion 2011;51(11):2262-4.
2011: Hagop Kantarjian; Charles Alan Schiffer; Alan Burnett
Hematologic malignancies: where do we stand in 2011?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(5):473-4.
2011: Maxim Norkin; Joseph Primo Uberti; Charles Alan Schiffer
Very late recurrences of leukemia: why does leukemia awake after many years of dormancy?
Leukemia research 2011;35(2):139-44.
2011: Jason Valent; Charles Alan Schiffer
Thrombocytopenia and platelet transfusions in patients with cancer.
Cancer treatment and research 2011;157():251-65.
2011: Jason N Valent; Charles Alan Schiffer
Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.
Leukemia research 2011;35(1):e1-3.
2010: Martin S Tallman; Haesook T Kim; Pau Montesinos; Frederick R Appelbaum; Javier de la Serna; John M Bennett; Guillermo Deben; Clara D Bloomfield; Jose Gonzalez; James H Feusner; Marcos Gonzalez; Robert E Gallagher; Jose D Gonzalez-San Miguel; Richard A Larson; Gustavo Milone; Elisabeth Paietta; Chelo Rayon; Jacob M Rowe; Concha Rivas; Charles Alan Schiffer; Edo Vellenga; Lois Shepherd; James L Slack; Peter H Wiernik; Cheryl L Willman; Miguel A Sanz
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Blood 2010;116(25):5650-9.
2010: Peter L Greenberg; Charles A Koller; Z Ioav Cabantchik; Ghulam Warsi; Tara Glynos; Carole Paley; Charles Alan Schiffer
Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.
Leukemia research 2010;34(12):1560-5.
2010: Charles Alan Schiffer
CML: how low can you go?
Blood 2010;116(19):3686-7.
2010: Maxim Norkin; Charles Alan Schiffer
Molecular monitoring of BCR-ABL transcripts in patients with chronic myelogenous leukemia: is high sensitivity of clinical value?
Current hematologic malignancy reports 2010;5(2):88-94.
2010: Charles Alan Schiffer
"I am older, not elderly," said the patient with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):521-3.
2009: John Gregory; Haesook Kim; Todd Alonzo; Rob Gerbing; William Woods; Howard Weinstein; Lois Shepherd; Charles Alan Schiffer; Frederick Appelbaum; Cheryl Willman; Peter Wiernik; Jacob Rowe; Martin S Tallman; James Feusner
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.
Pediatric blood & cancer 2009;53(6):1005-10.
2009: Sridhar Srinivasan; Charles Alan Schiffer
Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
Leukemia research 2009;33(4):561-4.
2009: Rod Ramchandren; Charles Alan Schiffer
Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia.
Biologics : targets & therapy 2009;3():205-14.
2008: Charles Alan Schiffer
Molecular characterization of AML: a significant advance or just another prognostic factor?
Best practice & research. Clinical haematology 2008;21(4):621-8.
2008: Swati Pawa; Ahmad J Khalifa; Murray Ehrinpreis; Charles Alan Schiffer; Firdous A Siddiqui
Zinc toxicity from massive and prolonged coin ingestion in an adult.
The American journal of the medical sciences 2008;336(5):430-3.
2008: Sridhar Srinivasan; Charles Alan Schiffer
Current treatment options and strategies for myelodysplastic syndromes.
Expert opinion on pharmacotherapy 2008;9(10):1667-78.
2008: Tannu Sahay; Charles Alan Schiffer
Monitoring minimal residual disease in patients with chronic myeloid leukemia after treatment with tyrosine kinase inhibitors.
Current opinion in hematology 2008;15(2):134-9.
2008: Andrew Lamb; Charles Alan Schiffer; Dan Jones; Jorge Cortes
Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods.
Blood 2008;111(4):1774-80.
2008: Andreas Hochhaus; Brian J Druker; Charles Sawyers; françois guilhot; Charles Alan Schiffer; Jorge Cortes; Dietger Niederwieser; Carlo Gambacorti-Passerini; Carlo Gambacorti; Richard M Stone; John Goldman; Thomas Fischer; Stephen G O'Brien; Jose J Reiffers; Manisha Mone; Tillmann Krahnke; Moshe Talpaz; Hagop M Kantarjian
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.
Blood 2008;111(3):1039-43.
2008: Charles Alan Schiffer
World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes.
Seminars in hematology 2008;45(1):3-7.
2008: Azra Raza; James A Reeves; Eric J Feldman; Gordon W Dewald; John M Bennett; H Joachim Deeg; Luke Dreisbach; Charles Alan Schiffer; Richard M Stone; Peter L Greenberg; Peter T Curtin; Virginia Klimek; Jamile M Shammo; Deborah Thomas; Robert D Knight; Michele Schmidt; Kenton Wride; Jerome B Zeldis; Alan F List
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
Blood 2008;111(1):86-93.
2007: Charles Alan Schiffer
BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.
The New England journal of medicine 2007;357(3):258-65.
2007: Charles Alan Schiffer
Advances in MDS.
Clinical advances in hematology & oncology : H&O 2007;5(6):450-2.
2007: Ehab Atallah; Charles Alan Schiffer
Agent Orange, prostate cancer irradiation and acute promyelocyic leukemia (APL): is there a link?
Leukemia research 2007;31(5):720-1.
2007: Charles Alan Schiffer
Myelodysplasia: the good, the fair and the ugly.
Best practice & research. Clinical haematology 2007;20(1):49-55.
2006: Jeffrey A Zonder; Charles Alan Schiffer
Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.
Current hematologic malignancy reports 2006;1(3):141-51.
2006: Bruce D Cheson; Peter L Greenberg; John M Bennett; Bob Lowenberg; Pierre W Wijermans; Stephen D Nimer; Antonio Pinto; Miloslav Beran; Theo M de Witte; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Steven D Gore; Charles Alan Schiffer; Andrew Lamb
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.
Blood 2006;108(2):419-25.
2006: Navneet S Majhail; Charles Alan Schiffer; Daniel J Weisdorf
Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):789-91.
2006: Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George D Demetri; Christopher E Desch; Philip A Pizzo; Charles Alan Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade Iii; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3187-205.
2006: Richard A Larson; Richard M Stone; Robert J Mayer; Charles Alan Schiffer
Fifty years of clinical research by the leukemia committee of the cancer and leukemia group B.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3556s-63s.
2006: Bhaumik B Patel; Anwar N Mohamed; Charles Alan Schiffer
"Acute myelogenous leukemia like" translocations in CML blast crisis: two new cases of inv(16)/t(16;16) and a review of the literature.
Leukemia research 2006;30(2):225-32.
2006: Charles Alan Schiffer
Clinical issues in the management of patients with myelodysplasia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():205-10.
2006: Ehab Atallah; Charles Alan Schiffer
Granulocyte transfusion.
Current opinion in hematology 2006;13(1):45-9.
2005: Charles Alan Schiffer
Use of myeloid growth factors for patients with febrile neutropenia: plus ca change, plus c'est la même chose.
Pediatric blood & cancer 2005;45(3):242-3.
2005: Guido Marcucci; Krzysztof Mrózek; Amy S Ruppert; Kati Maharry; Jonathan E Kolitz; Joseph O Moore; Robert J Mayer; Mark J Pettenati; Bayard L Powell; Colin G Edwards; Lisa J Sterling; James W Vardiman; Charles Alan Schiffer; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5705-17.
2005: Sherrill J Slichter; Kathryn Davis; Helen Enright; Hayden Braine; Terry Gernsheimer; Kuo-Jang Kao; Thomas S Kickler; Edward J Lee; Janice McFarland; Jeffrey McCullough; Glenn Rodey; Charles Alan Schiffer; Robert Woodson
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.
Blood 2005;105(10):4106-14.
2005: Joseph O Moore; Stephen L George; Richard K Dodge; Philip C Amrein; Bayard L Powell; Jonathan E Kolitz; Maria R Baer; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Charles Alan Schiffer
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
Blood 2005;105(9):3420-7.
2005: Chin Y Liu; Rosalyn P Sims-McCallum; Charles Alan Schiffer
A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy.
Leukemia research 2005;29(4):463-5.
2005: Charles Alan Schiffer
"3+7" therapy for the treatment of acute myeloid leukemia. PRO.
Clinical advances in hematology & oncology : H&O 2005;3(2):127-9.
2005: Sherif S Farag; Amy S Ruppert; Krzysztof Mrózek; Robert J Mayer; Richard M Stone; Andrew J Carroll; Bayard L Powell; Joseph O Moore; Mark J Pettenati; Prasad R K Koduru; Judith Stamberg; Maria R Baer; AnneMarie W Block; James W Vardiman; Jonathan E Kolitz; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):482-93.
2005: John C Byrd; Kanti Rai; Bercedis L Peterson; Frederick R Appelbaum; Vicki A Morrison; Jonathan E Kolitz; Lois Shepherd; John D Hines; Charles Alan Schiffer; Richard A Larson
Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.
Blood 2005;105(1):49-53.
2004: Mikkael A Sekeres; Bercedis Peterson; Richard K Dodge; Robert J Mayer; Joseph O Moore; Edward J Lee; Jonathan E Kolitz; Maria R Baer; Charles Alan Schiffer; Andrew J Carroll; James W Vardiman; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Richard M Stone
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood 2004;103(11):4036-42.
2004: David A Rizzieri; Jeffrey L Johnson; Donna Niedzwiecki; Edward J Lee; James W Vardiman; Bayard L Powell; Maurice Barcos; Clara D Bloomfield; Charles Alan Schiffer; Bruce A Peterson; George P Canellos; Richard A Larson
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
Cancer 2004;100(7):1438-48.
2004: Grover C Bagby; Jeffrey Lipton; Elaine M Sloand; Charles Alan Schiffer
Marrow failure.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():318-36.
2003: Bruce D Cheson; John M Bennett; Kenneth J Kopecky; Thomas Büchner; Cheryl L Willman; Elihu H Estey; Charles Alan Schiffer; Hartmut Doehner; Martin S Tallman; T Andrew Lister; Francesco Lo Coco; Rein Willemze; Andrea Biondi; Wolfgang Hiddemann; Richard A Larson; Bob Löwenberg; Miguel A Sanz; David R Head; Ryuzo Ohno; Clara D Bloomfield; Francesco LoCocco
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4642-9.
2003: Richard A Larson; G Q Daley; Charles Alan Schiffer; P Porcu; Ching-Hon Pui; J-P Marie; Linda Steelman; F E Bertrand; J A McCubrey
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.
Leukemia 2003;17(12):2358-82.
2003: Charles Alan Schiffer
Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia.
The New England journal of medicine 2003;349(8):727-9.
2003: Jeffrey A Zonder; Pamela Pemberton; Helen Brandt; Anwar N Mohamed; Charles Alan Schiffer
The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2092-7.
2003: Anwar N Mohamed; Pamela Pemberton; Jeffrey A Zonder; Charles Alan Schiffer
The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1333-7.
2003: Ronald A Sacher; Thomas S Kickler; Charles Alan Schiffer; Laurence A Sherman; Arthur W Bracey; Ira A Shulman
Management of patients refractory to platelet transfusion.
Archives of pathology & laboratory medicine 2003;127(4):409-14.
2003: Charles Alan Schiffer; R Hehlmann; Richard Larson
Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL(1).
Leukemia 2003;17(4):691-9.
2003: Ted P Szatrowski; Richard K Dodge; Carol Reynolds; Carol A Westbrook; Stanley R Frankel; Jeffrey Sklar; Carleton C Stewart; David D Hurd; Jonathan E Kolitz; Enrique Velez-Garcia; Richard M Stone; Clara D Bloomfield; Charles Alan Schiffer; Richard A Larson
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.
Cancer 2003;97(6):1471-80.
2003: Maria E Dan; Charles Alan Schiffer
Strategies for managing refractoriness to platelet transfusions.
Current hematology reports 2003;2(2):158-64.
2003: Charles Alan Schiffer
Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):760-1.
2003: John C Byrd; B Peterson; Lawrence D Piro; Alan Saven; James W Vardiman; Richard A Larson; Charles Alan Schiffer
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
Leukemia 2003;17(2):323-7.
2003: Jeffrey A Zonder; Charles Alan Schiffer
Practical aspects of the treatment of chronic myelogenous leukemia with imatinib mesylate.
Current hematology reports 2003;2(1):57-64.
2003: Richard T Silver; Bercedis L Peterson; Ted P Szatrowski; Bayard L Powell; Wendy Stock; Andrew J Carroll; Clara D Bloomfield; Charles Alan Schiffer; Richard A Larson
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.
Leukemia & lymphoma 2003;44(1):39-48.
2003: John C Byrd; Bercedis L Peterson; Vicki A Morrison; Kathleen Park; Robert Jacobson; Eva Hoke; James W Vardiman; Kanti Rai; Charles Alan Schiffer; Richard A Larson
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).
Blood 2003;101(1):6-14.
2002: John C Byrd; Krzysztof Mrózek; Richard K Dodge; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Shivanand R Patil; Kathleen W Rao; Michael S Watson; Prasad R K Koduru; Joseph O Moore; Richard M Stone; Robert J Mayer; Eric J Feldman; Frederick R Davey; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
Blood 2002;100(13):4325-36.
2002: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; William G Woods; Angela Ogden; Howard Weinstein; Lois Shepherd; Cheryl Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
Blood 2002;100(13):4298-302.
2002: Jeffrey A Zonder; Michael Keating; Charles Alan Schiffer
Chronic lymphocytic leukemia presenting in association with aplastic anemia.
American journal of hematology 2002;71(4):323-7.
2002: Vicki A Morrison; Kanti Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Richard A Larson; Charles Alan Schiffer
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(18):3878-84.
2002: Oliver G Ottmann; Brian J Druker; Charles L Sawyers; John M Goldman; Josy Reiffers; Richard T Silver; Sante Tura; Thomas Fischer; Michael W N Deininger; Charles Alan Schiffer; Michele Baccarani; Alois Gratwohl; Andreas Hochhaus; Dieter Hoelzer; Sofia Fernandes-Reese; Insa Gathmann; Renaud Capdeville; Stephen G O'Brien
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias.
Blood 2002;100(6):1965-71.
2002: Sherif S Farag; Stephen L George; Edward J Lee; Maria R Baer; Richard K Dodge; Brian Becknell; Todd A Fehniger; Lewis R Silverman; Jeffrey Crawford; Clara D Bloomfield; Richard A Larson; Charles Alan Schiffer; Michael A Caligiuri
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2812-9.
2002: Maria R Baer; Stephen L George; Richard K Dodge; Kieran L O'Loughlin; Hans Minderman; Michael A Caligiuri; John Anastasi; Bayard L Powell; Jonathan E Kolitz; Charles Alan Schiffer; Clara D Bloomfield; Richard A Larson
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
Blood 2002;100(4):1224-32.
2002: Robert E Martell; Bercedis L Peterson; Harvey Jay Cohen; William P Petros; Kanti Rai; Vicki A Morrison; Laurence Elias; Lois Shepherd; John Hines; Richard A Larson; Charles Alan Schiffer; Herbert I Hurwitz
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Cancer chemotherapy and pharmacology 2002;50(1):37-45.
2002: Alice B Kornblith; James E Herndon; Lewis R Silverman; Erin P Demakos; Rosalie Odchimar-Reissig; James F Holland; Bayard L Powell; Carlos DeCastro; John Ellerton; Richard A Larson; Charles Alan Schiffer; Jimmie C Holland
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2441-52.
2002: Lewis R Silverman; Erin P Demakos; Bercedis L Peterson; Alice B Kornblith; Jimmie C Holland; Rosalie Odchimar-Reissig; Richard M Stone; Douglas Nelson; Bayard L Powell; Carlos M DeCastro; John Ellerton; Richard A Larson; Charles Alan Schiffer; James F Holland
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2429-40.
2002: Charles L Sawyers; Andreas Hochhaus; Eric Feldman; John M Goldman; Carole B Miller; Oliver G Ottmann; Charles Alan Schiffer; Moshe Talpaz; françois guilhot; Michael W N Deininger; Thomas Fischer; Steve G O'Brien; Richard M Stone; Carlo B Gambacorti-Passerini; Nigel H Russell; Jose J Reiffers; Thomas C Shea; Bernard Chapuis; Steven Coutre; Sante Tura; Enrica Morra; Richard A Larson; Alan Saven; Christian Peschel; Alois Gratwohl; Franco Mandelli; Monique Ben-Am; Insa Gathmann; Renaud Capdeville; Ronald L Paquette; Brian J Druker
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.
Blood 2002;99(10):3530-9.
2002: Charles Alan Schiffer
Postremission therapy in older adults with acute myeloid leukemia: an opportunity for new drug development.
Leukemia 2002;16(4):745-7.
2002: Moshe Talpaz; Richard T Silver; Brian J Druker; John M Goldman; Carlo Gambacorti-Passerini; françois guilhot; Charles Alan Schiffer; Thomas Fischer; Michael W N Deininger; Anne L Lennard; Andreas Hochhaus; Oliver G Ottmann; Alois Gratwohl; Michele Baccarani; Richard Stone; Sante Tura; Francois-Xavier Mahon; Sofia Fernandes-Reese; Insa Gathmann; Renaud Capdeville; Hagop M Kantarjian; Charles L Sawyers
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.
Blood 2002;99(6):1928-37.
2002: Hagop Kantarjian; Charles Sawyers; Andreas Hochhaus; françois guilhot; Charles Alan Schiffer; Carlo Gambacorti-Passerini; Dietger Niederwieser; Debra Resta; Renaud Capdeville; Ulrike Zoellner; Moshe Talpaz; Brian J Druker; John Goldman; Stephen G O'Brien; Nigel Russell; Thomas Fischer; Oliver Ottmann; Pascale Cony-Makhoul; Thierry Facon; Richard Stone; Carole B Miller; Martin S Tallman; Randy Brown; Michael Schuster; Thomas Loughran; Alois Gratwohl; Franco Mandelli; Giuseppe Saglio; Mario Lazzarino; Domenico Russo; Michele Baccarani; Enrica Morra
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
The New England journal of medicine 2002;346(9):645-52.
2001: Charles Alan Schiffer
Diagnosis and management of refractoriness to platelet transfusion.
Blood reviews 2001;15(4):175-80.
2001: Edward J Lee; Gina R Petroni; Charles Alan Schiffer; C E Freter; Jeffrey L Johnson; Maurice Barcos; Glauco Frizzera; Clara D Bloomfield; Bruce A Peterson
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(20):4014-22.
2001: Charles Alan Schiffer
Signal transduction inhibition: changing paradigms in cancer care.
Seminars in oncology 2001;28(5 Suppl 17):34-9.
2001: Charles Alan Schiffer
Treatment of high-grade lymphoid malignancies in adults.
Seminars in hematology 2001;38(4 Suppl 10):22-6.
2001: Bruce D Cheson; John M Bennett; Andrew Lamb; Charles Alan Schiffer; Stephen D Nimer; B Löwenberg; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Pierre W Wijermans; Peter L Greenberg
Myelodysplastic syndromes standardized response criteria: further definition.
Blood 2001;98(6):1985.
2001: Charles Alan Schiffer
STI-571: current status and future prospects.
Current opinion in investigational drugs (London, England : 2000) 2001;2(9):1279-81.
2001: Vicki A Morrison; Kanti Rai; Bercedis L Peterson; Jonathan E Kolitz; Laurence Elias; Frederick R Appelbaum; John D Hines; Lois Shepherd; Robert E Martell; Richard A Larson; Charles Alan Schiffer
Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3611-21.
2001: Charles Alan Schiffer
Acute myeloid leukemia in adults: where do we go from here?
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S45-52.
2001: Richard M Stone; D T Berg; Stephen L George; Richard K Dodge; P A Paciucci; Philip Schulman; Edward J Lee; Joseph O Moore; Bayard L Powell; Maria R Baer; Clara D Bloomfield; Charles Alan Schiffer
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
Blood 2001;98(3):548-53.
2001: Maria R Baer; Carleton C Stewart; Richard K Dodge; G Leget; N Sulé; Krzysztof Mrózek; Charles Alan Schiffer; Bayard L Powell; Jonathan E Kolitz; Joseph O Moore; Richard M Stone; Frederick R Davey; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
Blood 2001;97(11):3574-80.
2001: Charles Alan Schiffer
Management of patients refractory of platelet transfusion.
Leukemia 2001;15(4):683-5.
2001: Charles Alan Schiffer; Kenneth C Anderson; Charles L Bennett; S Bernstein; Linda S Elting; M Goldsmith; M Goldstein; H Hume; J J McCullough; R E McIntyre; B L Powell; J M Rainey; S D Rowley; Paolo Rebulla; M B Troner; A H Wagnon
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1519-38.
2000: Kanti Rai; Bercedis L Peterson; Frederick R Appelbaum; Jonathan E Kolitz; Laurence Elias; Lois Shepherd; John Hines; G A Threatte; Richard A Larson; B D Cheson; Charles Alan Schiffer
Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
The New England journal of medicine 2000;343(24):1750-7.
2000: Bruce D Cheson; John M Bennett; Andrew Lamb; A Pinto; Charles Alan Schiffer; Stephen D Nimer; B Löwenberg; M Beran; T M de Witte; Richard M Stone; Moshe Mittelman; Guillermo F Sanz; Pierre W Wijermans; Steven D Gore; Peter L Greenberg
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
Blood 2000;96(12):3671-4.
2000: Howard Ozer; J O Armitage; Charles L Bennett; Jeffrey Crawford; George D Demetri; P A Pizzo; Charles Alan Schiffer; Thomas J Smith; G Somlo; J C Wade; James L Wade Iii; Rodger J Winn; Antoinette J Wozniak; Mark R Somerfield
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3558-85.
2000: Charles Alan Schiffer; K Miller; R A Larson; P C Amrein; J H Antin; V J Zani; R M Stone
A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia.
Blood 2000;95(8):2530-5.
2000: Martee Hensley; B Peterson; Richard T Silver; Richard A Larson; Charles Alan Schiffer; Ted P Szatrowski
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1301-8.
2000: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; Angela Ogden; Lois Shepherd; Jacob M Rowe; C François; Richard Larson; Peter H Wiernik
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.
Blood 2000;95(1):90-5.
1999: John C Byrd; Richard K Dodge; Andrew J Carroll; Maria R Baer; C Edwards; Judith Stamberg; Mazin B Qumsiyeh; Joseph O Moore; Robert J Mayer; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3767-75.
1999: Michael Glantz; S LaFollette; Kurt A Jaeckle; W Shapiro; Lode J Swinnen; J R Rozental; Surasak Phuphanich; Lisa R Rogers; John C Gutheil; Tracy T Batchelor; D Lyter; M Chamberlain; Bernard L Maria; Charles Alan Schiffer; R Bashir; D Thomas; W Cowens; Stephen B Howell
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3110-6.
1999: Edward J Lee; Stephen L George; M Caligiuri; Ted P Szatrowski; Bayard L Powell; S Lemke; Richard K Dodge; Ruth Smith; Maria R Baer; Charles Alan Schiffer
Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2831-9.
1999: Robert Peter Gale; RE Park; RW Dubois; GP Herzig; WG Hocking; mary m horowitz; A Keating; Sanford J. Kempin; Charles Linker; Charles Alan Schiffer; PH Wiernik; DJ Weisdorf; Kanti Rai
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase.
Leukemia research 1999;23(9):817-26.
1999: Robert Peter Gale; RE Park; RW Dubois; GP Herzig; WG Hocking; mary m horowitz; A Keating; Sanford J. Kempin; Charles Linker; Charles Alan Schiffer; PH Wiernik; DJ Weisdorf; Kanti Rai
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.
Leukemia research 1999;23(8):709-18.
1999: Meir Wetzler; Richard K Dodge; Krzysztof Mrózek; Andrew J Carroll; Ramana Tantravahi; A W Block; Mark J Pettenati; Michelle M Le Beau; Stanley R Frankel; Carleton C Stewart; Ted P Szatrowski; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience.
Blood 1999;93(11):3983-93.
1999: Myron S Czuczman; Richard K Dodge; Carleton C Stewart; Stanley R Frankel; Frederick R Davey; Bayard L Powell; Ted P Szatrowski; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.
Blood 1999;93(11):3931-9.
1999: Charles Alan Schiffer
Granulocyte transfusion therapy.
Current opinion in hematology 1999;6(1):3-7.
1999: Charles Alan Schiffer
Leukemia.
Current opinion in oncology 1999;11(1):1-2.
1998: Robert Peter Gale; RE Park; RW Dubois; GP Herzig; WG Hocking; mary m horowitz; A Keating; Sanford J. Kempin; Charles Linker; Charles Alan Schiffer; PH Wiernik; DJ Weisdorf; Kanti Rai
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remission.
Leukemia research 1998;22(11):973-81.
1998: Clara D Bloomfield; David S Lawrence; John C Byrd; Andrew J Carroll; Mark J Pettenati; Ramana Tantravahi; Shivanand R Patil; Frederick R Davey; D T Berg; Charles Alan Schiffer; Diane C Arthur; Robert J Mayer
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Cancer research 1998;58(18):4173-9.
1998: Richard A Larson; Richard K Dodge; C A Linker; Richard M Stone; Bayard L Powell; Edward J Lee; Philip Schulman; Frederick R Davey; Stanley R Frankel; Clara D Bloomfield; Stephen L George; Charles Alan Schiffer
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
Blood 1998;92(5):1556-64.
1998: K Heinonen; Krzysztof Mrózek; David S Lawrence; Diane C Arthur; Mark J Pettenati; Judith Stamberg; Mazin B Qumsiyeh; R S Verma; J MacCallum; Charles Alan Schiffer; Clara D Bloomfield
Clinical characteristics of patients with de novo acute myeloid leukaemia and isolated trisomy 11: a Cancer and Leukemia Group B study.
British journal of haematology 1998;101(3):513-20.
1998: John C Byrd; David S Lawrence; Diane C Arthur; Mark J Pettenati; Ramana Tantravahi; Mazin B Qumsiyeh; Judith Stamberg; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1235-41.
1998: Richard A Larson; M H Fretzin; Richard K Dodge; Charles Alan Schiffer
Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
Leukemia 1998;12(5):660-5.
1998: Alice B Kornblith; James E Herndon; Enid Zuckerman; David Cella; E Cherin; S Wolchok; Raymond B Weiss; L F Diehl; E Henderson; M Robert Cooper; Charles Alan Schiffer; George P Canellos; Robert J Mayer; R T Silver; A Schilling; Bruce A Peterson; D Greenberg; Jimmie C Holland
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):297-306.
1998: Clarence Sarkodee-Adoo; J M Kendall; R Sridhara; Edward J Lee; Charles Alan Schiffer
The relationship between the duration of platelet storage and the development of transfusion reactions.
Transfusion 1998;38(3):229-35.
1998: Maria R Baer; Carleton C Stewart; David S Lawrence; Diane C Arthur; Krzysztof Mrózek; Matthew P Strout; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Leukemia 1998;12(3):317-25.
1998: Edward J Lee; Stephen L George; Philip C Amrein; P A Paciucci; Steven Allen; Charles Alan Schiffer
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B.
Leukemia 1998;12(2):139-43.
1998: Charles Alan Schiffer
Opportunities for the use of thrombopoietic growth factors.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():249-53.
1998: M Tarek Elghetany; B Peterson; J MacCallum; D A Nelson; J F Varney; A K Sullivan; L R Silverman; Charles Alan Schiffer; Frederick R Davey; Clara D Bloomfield
Double esterase staining and other neutrophilic granule abnormalities in 237 patients with the myelodysplastic syndrome studied by the cancer and leukemia group B.
Acta haematologica 1998;100(1):13-6.
1998: Michael A Caligiuri; Matthew P Strout; David S Lawrence; Diane C Arthur; Maria R Baer; F Yu; S Knuutila; Krzysztof Mrózek; AR Oberkircher; Guido Marcucci; ALBERT DE LA CHAPELLE; Erkki Elonen; A W Block; P N Rao; Geoffrey P Herzig; B L Powell; T Ruutu; Charles Alan Schiffer; Clara D Bloomfield
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
Cancer research 1998;58(1):55-9.
1997: Charles Alan Schiffer; Richard K Dodge; R A Larson
Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia.
Cancer 1997;80(11 Suppl):2210-4.
1997: Krzysztof Mrózek; K Heinonen; David S Lawrence; Andrew J Carroll; Prasad R K Koduru; Kathleen W Rao; Matthew P Strout; R E Hutchison; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.
Blood 1997;90(11):4532-8.
1997: Donna B Greenberg; Alice B Kornblith; James E Herndon; Enid Zuckerman; Charles Alan Schiffer; Raymond B Weiss; Robert J Mayer; S M Wolchok; Jimmie C Holland
Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress.
Cancer 1997;80(10):1936-44.
1997: Martin S Tallman; Janet W Andersen; Charles Alan Schiffer; Frederick R Appelbaum; James Feusner; Angela Ogden; Lois Shepherd; C Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
All-trans-retinoic acid in acute promyelocytic leukemia.
The New England journal of medicine 1997;337(15):1021-8.
1997: Ann Farese; Charles Alan Schiffer; Thomas J MacVittie
The impact of thrombopoietin and related Mpl-ligands on transfusion medicine.
Transfusion medicine reviews 1997;11(4):243-55.
1997: M Tarek Elghetany; B Peterson; J MacCallum; D A Nelson; J F Varney; A K Sullivan; L R Silverman; Charles Alan Schiffer; Frederick R Davey; Clara D Bloomfield
Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: a common deficiency in 216 patients studied by the Cancer and Leukemia Group B.
Leukemia research 1997;21(9):801-6.
1997: Robert E Gallagher; Cheryl L Willman; James L Slack; J W Andersen; YP Li; David S Viswanatha; Clara D Bloomfield; F R Appelbaum; Charles Alan Schiffer; Martin S Tallman; Peter H Wiernik
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
Blood 1997;90(4):1656-63.
1997: Maria R Baer; Carleton C Stewart; David S Lawrence; Diane C Arthur; John C Byrd; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Blood 1997;90(4):1643-8.
1997: E L Alonsozana; Judith Stamberg; D Kumar; E S Jaffe; L J Medeiros; Christopher Frantz; Charles Alan Schiffer; B A O'Connell; S Kerman; Sanford A Stass; Lynne V Abruzzo
Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma.
Leukemia 1997;11(8):1367-72.
1997: C A Hsu; Arun K Rishi; X Su-Li; TM Gerald; Marcia I Dawson; Charles Alan Schiffer; Uwe Reichert; B Shroot; GC Poirer; Joseph A Fontana
Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.
Blood 1997;89(12):4470-9.
1997: James L Slack; Diane C Arthur; David S Lawrence; Krzysztof Mrózek; Robert J Mayer; Frederick R Davey; Ramana Tantravahi; Mark J Pettenati; S Bigner; Andrew J Carroll; Kathleen W Rao; Charles Alan Schiffer; Clara D Bloomfield
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1786-95.
1997: Manfred Jücker; Charles Alan Schiffer; Ricardo A Feldman
A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells.
Blood 1997;89(6):2024-35.
1997: John C Byrd; R B Weiss; Diane C Arthur; David S Lawrence; Maria R Baer; Frederick R Davey; E S Trikha; Andrew J Carroll; Ramana Tantravahi; Mazin B Qumsiyeh; Shivanand R Patil; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):466-75.
1997: Joseph O Moore; Richard K Dodge; Philip C Amrein; Jonathan E Kolitz; Edward J Lee; B Powell; S Godfrey; F Robert; Charles Alan Schiffer
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.
Blood 1997;89(3):780-8.
1997: CP Engelfriet; Henk W Reesink; R H Aster; A Brand; B Tomson; F H Claas; Marcela Contreras; Cristina Navarrete; J Jørgensen; M F Murphy; R Curtis; A H Waters; Simon Panzer; M Kurz; P Höcker; Wolfgang R Mayr; Charles Alan Schiffer
Management of alloimmunized, refractory patients in need of platelet transfusions.
Vox sanguinis 1997;73(3):191-8.
1997: Wendy Stock; Carol A Westbrook; B Peterson; D C Arthur; Ted P Szatrowski; Richard T Silver; Dorie A Sher; Ding Wu; Michelle M Le Beau; Charles Alan Schiffer; Clara D Bloomfield
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):26-36.
1996: Charles Alan Schiffer
Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia.
Blood 1996;88(10):3675-85.
1996: HARVEY KLEIN; R G Strauss; Charles Alan Schiffer
Granulocyte transfusion therapy.
Seminars in hematology 1996;33(4):359-68.
1996: Clarence Sarkodee-Adoo; Charles Alan Schiffer
Platelet transfusion support for patients with cancer and hematologic malignancies.
Current opinion in hematology 1996;3(5):347-54.
1996: Steven H Bernstein; V L Brunetto; Frederick R Davey; D Wurster-Hill; Robert J Mayer; Richard M Stone; Charles Alan Schiffer; Clara D Bloomfield
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2486-94.
1996: M A Hussein; Edward J Lee; R Fletcher; Charles Alan Schiffer
The effect of lymphocytotoxic antibody reactivity on the results of single antigen mismatched platelet transfusions to alloimmunized patients.
Blood 1996;87(9):3959-62.
1996: Michael A Caligiuri; Matthew P Strout; S A Schichman; Krzysztof Mrózek; Diane C Arthur; Geoffrey P Herzig; Maria R Baer; Charles Alan Schiffer; Kirsti Heinonen; S Knuutila; Tapio Nousiainen; T Ruutu; A W Block; P Schulman; J Pedersen-Bjergaard; Carlo M Croce; Clara D Bloomfield
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.
Cancer research 1996;56(6):1418-25.
1996: Charles Alan Schiffer
Leukemia.
Current opinion in oncology 1996;8(1):1-2.
1996: Douglas Ross; L Austin Doyle; Charles Alan Schiffer; Edward J Lee; Caroline E Grant; SUSAN COLE; Roger G Deeley; W Yang; Y Tong
Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Leukemia 1996;10(1):48-55.
1995: B A Sullivan; Charles Alan Schiffer; S R Patil; D Hulseberg; J Leana-Cox; Stuart Schwartz
Application of FISH to complex chromosomal rearrangements associated with chronic myelogenous leukemia.
Cancer genetics and cytogenetics 1995;82(2):93-9.
1995: Kanti Rai; F Davey; B Peterson; Charles Alan Schiffer; R T Silver; Howard Ozer; H Golomb; Clara D Bloomfield
Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B.
Leukemia 1995;9(7):1116-20.
1995: Richard M Stone; D T Berg; S L George; R K Dodge; P A Paciucci; P Schulman; Edward J Lee; J O Moore; B L Powell; Charles Alan Schiffer
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
The New England journal of medicine 1995;332(25):1671-7.
1995: L Austin Doyle; Douglas Ross; R Sridhara; A T Fojo; S H Kaufmann; Edward J Lee; Charles Alan Schiffer
Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells.
British journal of cancer 1995;71(1):52-8.
1995: Ronald A Fleming; R L Capizzi; Gary Rosner; L K Oliver; S J Smith; Charles Alan Schiffer; R T Silver; B A Peterson; R B Weiss; G A Omura
Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study.
Cancer chemotherapy and pharmacology 1995;36(5):425-30.
1994: HM Golomb; R Dodge; R Mick; D Budman; R Hutchison; S J Horning; Charles Alan Schiffer
Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
Leukemia 1994;8(12):2037-40.
1994: Robert J Mayer; R B Davis; Charles Alan Schiffer; D T Berg; B L Powell; P Schulman; G A Omura; J O Moore; O R McIntyre; Emil Frei
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
The New England journal of medicine 1994;331(14):896-903.
1994: H L Parnes; E Fung; Charles Alan Schiffer
Chemotherapy-induced lactose intolerance in adults.
Cancer 1994;74(5):1629-33.
1994: G A Omura; R T Perri; B Peterson; Charles Alan Schiffer
Carboplatin in previously treated multiple myeloma. A Cancer and Leukemia Group B phase II trial.
American journal of clinical oncology 1994;17(3):196-8.
1994: A Neubauer; R K Dodge; S L George; F R Davey; R T Silver; Charles Alan Schiffer; R J Mayer; E D Ball; D Wurster-Hill; C D Bloomfield
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.
Blood 1994;83(6):1603-11.
1994: Douglas Ross; P J Wooten; Y Tong; B Cornblatt; C Levy; R Sridhara; Edward J Lee; Charles Alan Schiffer
Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
Blood 1994;83(5):1337-47.
1994: Raymond B Weiss; B L Peterson; Steven Allen; S M Browning; D B Duggan; Charles Alan Schiffer
A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study.
Investigational new drugs 1994;12(1):41-3.
1994: V S Gharpure; D Norris; Edward J Lee; Charles Alan Schiffer
Use of 'split' plateletpheresis products for alloimmunized patients.
Vox sanguinis 1994;67(3):272-4.
1993: Dale P Sandler; D L Shore; James Robert Anderson; F R Davey; D Arthur; R J Mayer; R T Silver; R B Weiss; J O Moore; Charles Alan Schiffer
Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.
Journal of the National Cancer Institute 1993;85(24):1994-2003.
1993: Howard Ozer; S L George; Charles Alan Schiffer; Kathleen W Rao; P N Rao; D H Wurster-Hill; D D Arthur; B Powell; A Gottlieb; B A Peterson; Kanti Rai; J R Testa; M LeBeau; R Tantravahi; C D Bloomfield
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
Blood 1993;82(10):2975-84.
1993: V Gharpure; B O'Connell; Charles Alan Schiffer
Mezlocillin-induced thrombocytopenia.
Annals of internal medicine 1993;119(8):862.
1993: Edward J Lee; K Reck; C Carter; S Hodges; Charles Alan Schiffer
A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
Leukemia 1993;7(10):1500-3.
1993: Douglas Ross; P J Wooten; R Sridhara; J V Ordóñez; Edward J Lee; Charles Alan Schiffer
Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Blood 1993;82(4):1288-99.
1993: L R Silverman; J F Holland; R S Weinberg; BLANCHE ALTER; R B Davis; R R Ellison; E P Demakos; C J Cornell; R W Carey; Charles Alan Schiffer
Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes.
Leukemia 1993;7 Suppl 1():21-9.
1993: M R Cooper; K Dear; O R McIntyre; Howard Ozer; J Ellerton; George P Canellos; B Bernhardt; D Duggan; D Faragher; Charles Alan Schiffer
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):155-60.
1993: Charles Alan Schiffer; O R McIntyre
Age related changes in adults with acute leukemia.
Advances in experimental medicine and biology 1993;330():215-29.
1992: Carol A Westbrook; A L Hooberman; C Spino; Richard K Dodge; Richard A Larson; Frederick R Davey; D H Wurster-Hill; RE Sobol; Charles Alan Schiffer; Clara D Bloomfield
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
Blood 1992;80(12):2983-90.
1992: Edward J Lee; J Yang; Richard Leavitt; J R Testa; Curt I Civin; A Forrest; Charles Alan Schiffer
The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Leukemia 1992;6(11):1203-9.
1992: T Simon; Edward J Lee; A Heaton; Charles Alan Schiffer; D Huestis; D Schoendorfer; S Hedberg; D Buchholz
Storage and transfusion of platelets collected by an automated two-stage apheresis procedure.
Transfusion 1992;32(7):624-8.
1992: Frederick R Davey; David S Lawrence; J MacCallum; J Varney; R Hutchison; D Wurster-Hill; Charles Alan Schiffer; RE Sobol; N Ciminelli; M Le Beau
Morphologic characteristics of acute lymphoblastic leukemia (ALL) with abnormalities of chromosome 8, band q24.
American journal of hematology 1992;40(3):183-91.
1992: E H Rubin; J W Andersen; D T Berg; Charles Alan Schiffer; Robert J Mayer; Richard M Stone
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):948-53.
1992: Charles Alan Schiffer
Prophylactic platelet transfusion.
Transfusion 1992;32(4):295-8.
1992: B A O'Connell; Edward J Lee; KATE ROTHKO; M A Hussein; Charles Alan Schiffer
Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.
Blood 1992;79(2):527-31.
1992: H W Reesink; U E Nydegger; A Brand; R N Pietersz; G Andreu; J P Gmür; S Murphy; Charles Alan Schiffer; Thomas S Kickler
Should all platelet concentrates issued be leukocyte-poor?
Vox sanguinis 1992;62(1):57-64.
1992: R J Mayer; R B Davis; Charles Alan Schiffer; D T Berg; E Sarno; E Frei
Intensive post-remission therapy with Ara-C in adults with acute myeloid leukemia: initial results of a CALGB phase III trial. The Cancer and Leukemia Group B.
Leukemia 1992;6 Suppl 2():66-7.
1992: Charles Alan Schiffer; R A Larson; C D Bloomfield
Cancer and Leukemia Group B (CALGB) studies in adult acute lymhocytic leukemia.
Leukemia 1992;6 Suppl 2():171-4.
1991: R O Dillman; R B Davis; M R Green; R B Weiss; A J Gottlieb; S Caplan; S Kopel; H Preisler; O R McIntyre; Charles Alan Schiffer
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.
Blood 1991;78(10):2520-6.
1991: R R Ellison; R Mick; J Cuttner; Charles Alan Schiffer; R T Silver; E S Henderson; T Woliver; I Royston; Frederick R Davey; A S Glicksman
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):2002-15.
1991: Charles Alan Schiffer
Interferon studies in the treatment of patients with leukemia.
Seminars in oncology 1991;18(5 Suppl 7):1-6.
1991: Charles Alan Schiffer
Prevention of alloimmunization against platelets.
Blood 1991;77(1):1-4.
1990: Edward J Lee; Charles Alan Schiffer
Leukemias of indeterminant lineage.
Clinics in laboratory medicine 1990;10(4):737-54.
1990: P A Paciucci; R B Davis; J F Holland; O Martelo; Charles Alan Schiffer
Mitoxantrone and constant infusion etoposide for relapsed and refractory acute myelocytic leukemia.
American journal of clinical oncology 1990;13(6):516-9.
1990: Edward J Lee; D E Hogge; Robert E Gallagher; Charles Alan Schiffer
Low dose 5-azacytidine is ineffective for remission induction in patients with acute myeloid leukemia.
Leukemia 1990;4(12):835-8.
1990: P C Amrein; R B Davis; R J Mayer; Charles Alan Schiffer
Treatment of relapsed and refractory acute myeloid leukemia with diaziquone and mitoxantrone: a CALGB phase I study.
American journal of hematology 1990;35(2):80-3.
1990: M A Hussein; Charles Alan Schiffer; Edward J Lee
Incubation of platelet concentrates before transfusion does not improve posttransfusion recovery.
Transfusion 1990;30(8):701-3.
1990: M A Hussein; Edward J Lee; Charles Alan Schiffer
Platelet transfusions administered to patients with splenomegaly.
Transfusion 1990;30(6):508-10.
1990: Edward J Lee; Charles Alan Schiffer; T Tomiyasu; J R Testa
Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Leukemia 1990;4(5):350-3.
1990: B A O'Connell; Charles Alan Schiffer
Donor selection for alloimmunized patients by platelet crossmatching of random-donor platelet concentrates.
Transfusion 1990;30(4):314-7.
1990: Bruce D Cheson; Peter A Cassileth; D R Head; Charles Alan Schiffer; J M Bennett; C D Bloomfield; R Brunning; R P Gale; Michael R Grever; M J Keating
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):813-9.
1990: Janice P Dutcher; C Riggs; J J Fox; G S Johnston; D Norris; Peter H Wiernik; Charles Alan Schiffer
Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes.
American journal of hematology 1990;33(4):238-43.
1990: M R Heyman; Charles Alan Schiffer
Platelet transfusion therapy for the cancer patient.
Seminars in oncology 1990;17(2):198-209.
1990: Edward J Lee; K Reck; Charles Alan Schiffer
Continuous infusion diaziquone and etoposide: a phase I study in adult patients with acute leukemia.
Leukemia 1990;4(3):189-92.
1990: Charles Alan Schiffer
Granulocyte transfusions: an overlooked therapeutic modality.
Transfusion medicine reviews 1990;4(1):2-7.
1989: S L Hassinger; Charles Alan Schiffer; Chen-Chih Sun
Acute myeloblastic leukemia with extensive erythrophagocytosis mimicking malignant histiocytosis.
American journal of clinical pathology 1989;92(5):696-700.
1989: J W Karesh; EDWARD GOLDMAN; K Reck; S E Kelman; Edward J Lee; Charles Alan Schiffer
A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1528-32.
1989: Charles Alan Schiffer; B O'Connell; Edward J Lee
Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets.
Blood 1989;74(3):1172-6.
1989: Charles Alan Schiffer; Edward J Lee
Approaches to the therapy of relapsed acute myeloid leukemia.
Oncology (Williston Park, N.Y.) 1989;3(8):23-7; discussion 28.
1989: J P Dutcher; J Kendall; D Norris; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Granulocyte transfusion therapy and amphotericin B: adverse reactions?
American journal of hematology 1989;31(2):102-8.
1989: Edward J Lee; Charles Alan Schiffer
ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
Transfusion 1989;29(5):384-9.
1989: Bruce D Cheson; J M Bennett; Kanti Rai; Michael R Grever; N E Kay; M M Oken; Charles Alan Schiffer; M J Keating; D H Boldt; Sanford J. Kempin
Chronic lymphocytic leukemia: recommendations.
Annals of internal medicine 1989;110(8):664-5.
1989: Frederick R Davey; R B Davis; J M MacCallum; D A Nelson; Robert J Mayer; E D Ball; James D Griffin; Charles Alan Schiffer; Clara D Bloomfield
Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
American journal of hematology 1989;30(4):221-7.
1989: Charles Alan Schiffer; Edward J Lee; T Tomiyasu; P H Wiernik; J R Testa
Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia.
Blood 1989;73(1):263-70.
1988: Bruce D Cheson; J M Bennett; Kanti Rai; Michael R Grever; N E Kay; Charles Alan Schiffer; M M Oken; M J Keating; D H Boldt; Sanford J. Kempin
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
American journal of hematology 1988;29(3):152-63.
1988: Janice P Dutcher; Peter H Wiernik; S Markus; V Weinberg; Charles Alan Schiffer; K V Harwood
Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
Leukemia 1988;2(7):413-9.
1988: M R Heyman; Anuradha Chakravarthy; Bennett Edelman; S W Needleman; Charles Alan Schiffer
Failure of high-dose i.v. gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitors.
American journal of hematology 1988;28(3):191-4.
1988: Steven Fischkoff; J R Testa; Charles Alan Schiffer
Acute eosinophilic leukemia with a (10;11) chromosomal translocation.
Leukemia 1988;2(6):394-7.
1988: Edward J Lee; Merrill J Egorin; David A Van Echo; A E Cohen; N Tait; Charles Alan Schiffer
Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia.
Journal of the National Cancer Institute 1988;80(2):131-5.
1988: B O'Connell; Edward J Lee; Charles Alan Schiffer
The value of 10-minute posttransfusion platelet counts.
Transfusion 1988;28(1):66-7.
1988: P H Wiernik; Charles Alan Schiffer
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Journal of cancer research and clinical oncology 1988;114(1):105-7.
1987: Edward J Lee; Charles Alan Schiffer
Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients.
Blood 1987;70(6):1727-9.
1987: Charles Alan Schiffer; J C Wade
Supportive care: issues in the use of blood products and treatment of infection.
Seminars in oncology 1987;14(4):454-67.
1987: Edward J Lee; A Pollak; Richard Leavitt; J R Testa; Charles Alan Schiffer
Minimally differentiated acute nonlymphocytic leukemia: a distinct entity.
Blood 1987;70(5):1400-6.
1987: J F Bishop; Charles Alan Schiffer; Joseph Aisner; J P Matthews; P H Wiernik
Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients.
American journal of hematology 1987;26(2):147-55.
1987: J P Dutcher; Charles Alan Schiffer; P H Wiernik
Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(9):1364-72.
1987: Charles Alan Schiffer; R B Davis; R J Mayer; B A Peterson; Edward J Lee
Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study.
Cancer treatment reports 1987;71(9):879-80.
1987: G Helenglass; J R Testa; Charles Alan Schiffer
Philadelphia chromosome-positive acute leukemia: morphologic and clinical correlations.
American journal of hematology 1987;25(3):311-24.
1987: Douglas Ross; B W Thompson; C C Joneckis; S A Akman; Charles Alan Schiffer
Studies of ara-C metabolism in acute leukemia.
Seminars in oncology 1987;14(2 Suppl 1):182-91.
1987: R J Mayer; Charles Alan Schiffer; B A Peterson; D R Budman; R T Silver; Kanti Rai; G G Cornwell; R R Ellison; M Maguire; D T Berg
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
Seminars in oncology 1987;14(2 Suppl 1):25-31.
1987: Edward J Lee; D Norris; Charles Alan Schiffer
Intravenous immune globulin for patients alloimmunized to random donor platelet transfusion.
Transfusion 1987;27(3):245-7.
1987: Charles Alan Schiffer; E Patten; J Reilly; S Patel
Effective leukocyte removal from platelet preparations by centrifugation in a new pooling bag.
Transfusion 1987;27(2):162-4.
1987: E J Lee; Charles Alan Schiffer; S Misawa; J R Testa
Clinical and cytogenetic features of familial erythroleukaemia.
British journal of haematology 1987;65(3):313-20.
1987: Charles Alan Schiffer
Management of patients refractory to platelet transfusion--an evaluation of methods of donor selection.
Progress in hematology 1987;15():91-113.
1986: Eric R Fearon; P J Burke; B A Zehnbauer; Bert Vogelstein; Charles Alan Schiffer
Differentiation of blast cells in acute nonlymphocytic leukemia.
The New England journal of medicine 1986;315(23):1488.
1986: James D Griffin; R Davis; D A Nelson; F R Davey; R J Mayer; Charles Alan Schiffer; O R McIntyre; Clara D Bloomfield
Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
Blood 1986;68(6):1232-41.
1986: Eric R Fearon; P J Burke; Charles Alan Schiffer; B A Zehnbauer; Bert Vogelstein
Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia.
The New England journal of medicine 1986;315(1):15-24.
1986: Douglas Ross; C C Joneckis; Charles Alan Schiffer
Effects of verapamil on in vitro intracellular accumulation and retention of daunorubicin in blast cells from patients with acute nonlymphocytic leukemia.
Blood 1986;68(1):83-8.
1986: Douglas Ross; B W Thompson; C C Joneckis; S A Akman; Charles Alan Schiffer
Metabolism of ara-C by blast cells from patients with ANLL.
Blood 1986;68(1):76-82.
1986: Charles Alan Schiffer; Edward J Lee; Paul M Ness; J Reilly
Clinical evaluation of platelet concentrates stored for one to five days.
Blood 1986;67(6):1591-4.
1986: D E Hogge; B W Thompson; Charles Alan Schiffer
Platelet storage for 7 days in second-generation blood bags.
Transfusion 1986;26(2):131-5.
1986: S Misawa; Edward J Lee; Charles Alan Schiffer; Z Liu; J R Testa
Association of the translocation (15;17) with malignant proliferation of promyelocytes in acute leukemia and chronic myelogenous leukemia at blastic crisis.
Blood 1986;67(2):270-4.
1986: Edward J Lee; David A Van Echo; Merrill J Egorin; M S Nayar; P Shulman; Charles Alan Schiffer
Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.
Blood 1986;67(1):182-7.
1985: Charles Alan Schiffer; K Anderson; M Coleman; J Cuttner
Therapy for chronic myelogenous leukemia in blast crisis with etoposide and 5-azacitidine administered by continuous infusion: a Cancer and Leukemia group B Study.
Cancer treatment reports 1985;69(9):1027-8.
1985: R J Mayer; Charles Alan Schiffer; B A Peterson; R T Silver; G G Cornwell; O R McIntyre; Kanti Rai; D R Budman; R R Ellison; M Maguire
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study.
Seminars in oncology 1985;12(2 Suppl 3):84-90.
1985: Edward J Lee; Charles Alan Schiffer
Evidence for rapid mobilization of platelets from the spleen during intensive plateletpheresis.
American journal of hematology 1985;19(2):161-5.
1985: RE Sobol; I Royston; T W LeBien; J Minowada; K Anderson; Frederick R Davey; J Cuttner; Charles Alan Schiffer; R R Ellison; Clara D Bloomfield
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies.
Blood 1985;65(3):730-5.
1985: Charles Alan Schiffer
Single donor platelet transfusion.
Haematology and blood transfusion 1985;29():132-6.
1984: Charles Alan Schiffer; D E Hogge; Joseph Aisner; J P Dutcher; Edward J Lee; D Papenberg
High-dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients.
Blood 1984;64(4):937-40.
1984: D E Hogge; J P Dutcher; Joseph Aisner; Charles Alan Schiffer
The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients.
Blood 1984;64(1):253-6.
1984: D E Hogge; S Misawa; J R Testa; Richard Leavitt; A Pollak; Charles Alan Schiffer
Unusual karyotypic changes and B cell involvement in a case of lymph node blast crisis of chronic myelogenous leukemia.
Blood 1984;64(1):123-30.
1984: J P Dutcher; Charles Alan Schiffer; Joseph Aisner; B A O'Connell; C Levy; J A Kendall; P H Wiernik
Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors.
Cancer 1984;53(3):557-62.
1984: D E Hogge; S Misawa; Charles Alan Schiffer; J R Testa
Promyelocytic blast crisis in chronic granulocytic leukemia with 15;17 translocation.
Leukemia research 1984;8(6):1019-23.
1984: J P Dutcher; Joseph Aisner; D E Hogge; Charles Alan Schiffer
Donor reaction to hydroxyethyl starch during granulocytapheresis.
Transfusion 1984;24(1):66-7.
1983: Charles Alan Schiffer; J P Dutcher; Joseph Aisner; D Hogge; P H Wiernik; J P Reilly
A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
Blood 1983;62(4):815-20.
1983: J C Wade; M Gaffey; P H Wiernik; Stephen C Schimpff; Charles Alan Schiffer; M Wesley; J H Hoofnagle
Hepatitis in patients with acute nonlymphocytic leukemia.
The American journal of medicine 1983;75(3):413-22.
1983: J P Dutcher; Charles Alan Schiffer; G S Johnston; D Papenburg; P A Daly; Joseph Aisner; P H Wiernik
Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection.
Blood 1983;62(2):354-60.
1983: Charles Alan Schiffer; Joseph Aisner; J P Dutcher; P H Wiernik
Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia.
American journal of hematology 1983;15(1):65-74.
1983: Charles Alan Schiffer; C Keller; J P Dutcher; Joseph Aisner; D Hogge; P H Wiernik
Potential HLA-matched platelet donor availability for alloimmunized patients.
Transfusion 1983;23(4):286-9.
1983: D E Hogge; J P Dutcher; Joseph Aisner; Charles Alan Schiffer
Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion.
American journal of hematology 1983;14(4):363-9.
1983: K Van Sloten; P H Wiernik; Charles Alan Schiffer; Stephen C Schimpff
Evaluation of levamisole as an adjuvant to chemotherapy for treatment of ANLL.
Cancer 1983;51(9):1576-80.
1983: D E Hogge; Charles Alan Schiffer
Collection of platelets depleted of red and white cells with the "surge pump" adaptation of a blood cell separator.
Transfusion 1983;23(3):177-81.
1983: Charles Alan Schiffer
Granulocyte transfusion therapy.
Cancer treatment reports 1983;67(2):113-9.
1983: Charles Alan Schiffer; V Young
Detection of platelet antibodies using a micro-enzyme-linked immunosorbent assay (ELISA).
Blood 1983;61(2):311-7.
1983: Charles Alan Schiffer; Joseph Aisner; J P Dutcher
Platelet cryopreservation using dimethyl sulfoxide.
Annals of the New York Academy of Sciences 1983;411():161-9.
1983: S Murphy; Charles Alan Schiffer; A J Katz
Platelet concentrates: functional considerations, storage, and quality control.
Journal of clinical apheresis 1983;1(3):185-9.
1982: Charles Alan Schiffer; S J Slichter
Sounding board: Platelet transfusions from single donors.
The New England journal of medicine 1982;307(4):245-8.
1982: Dean E Brenner; C Garbino; H Kasdorf; U Villasanta; R Polcaro; J Yovarone; Joseph Aisner; Charles Alan Schiffer; P H Wiernik
A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies.
American journal of clinical oncology 1982;5(3):291-5.
1982: B Kotelba-Witkowska; Charles Alan Schiffer
Cryopreservation of platelet concentrates using glycerol-glucose.
Transfusion 1982;22(2):121-4.
1982: Charles Alan Schiffer; R DeBellis; H Kasdorf; P H Wiernik
Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacitidine and VP-16-213.
Cancer treatment reports 1982;66(2):267-71.
1982: Charles Alan Schiffer; Joseph Aisner; J P Dutcher; P A Daly; P H Wiernik
A clinical program of platelet cryopreservation.
Progress in clinical and biological research 1982;88():165-80.
1981: J P Dutcher; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.
Blood 1981;58(5):1007-11.
1981: B Kotelba-Witkowska; D M Harmening-Pittiglio; Charles Alan Schiffer
Storage of platelet concentrates using ion exchange resin charged with dibasic phosphate..
Blood 1981;58(3):537-43.
1981: J P Dutcher; Charles Alan Schiffer; G S Johnston
Rapid migration of 111indium-labeled granulocytes to sites of infection.
The New England journal of medicine 1981;304(10):586-9.
1981: J P Dutcher; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
Blood 1981;57(3):395-8.
1981: Joseph Aisner; Charles Alan Schiffer; P A Daly; D H Buchholz
Evaluation of gravity leukapheresis and comparison with intermittent centrifugation leukapheresis.
Transfusion 1981;21(1):100-6.
1980: L J Love; Stephen C Schimpff; Charles Alan Schiffer; P H Wiernik
Improved prognosis for granulocytopenic patients with gram-negative bacteremia.
The American journal of medicine 1980;68(5):643-8.
1980: P A Daly; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations.
JAMA : the journal of the American Medical Association 1980;243(5):435-8.
1980: Charles Alan Schiffer
Granulocyte transfusions--an established or still an experimental therapeutic procedure?
Vox sanguinis 1980;38(1):56-8.
1980: P A Daly; Charles Alan Schiffer; P H Wiernik
Acute promyelocytic leukemia--clinical management of 15 patients.
American journal of hematology 1980;8(4):347-59.
1979: P A Daly; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis.
Transfusion 1979;19(6):778-81.
1979: P A Daly; Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Successful transfusion of platelets cryopreserved for more than 3 years.
Blood 1979;54(5):1023-7.
1979: Charles Alan Schiffer; Joseph Aisner; P A Daly; Stephen C Schimpff; P H Wiernik
Alloimmunization following prophylactic granulocyte transfusion.
Blood 1979;54(4):766-74.
1979: K M Lichtenfeld; Charles Alan Schiffer; M Helrich
Platelet aggregation during and after general anesthesia and surgery.
Anesthesia and analgesia 1979;58(4):293-6.
1979: K M Lichtenfeld; Charles Alan Schiffer
The effect of dexamethasone on platelet function.
Transfusion 1979;19(2):169-72.
1979: Charles Alan Schiffer; Joseph Aisner; P A Daly; P H Wiernik
Increased leukocyte alkaline phosphatase activity following transfusion of leukocytes from a patient with chronic myelogenous leukemia.
The American journal of medicine 1979;66(3):519-22.
1979: P A Daly; R Simon; Charles Alan Schiffer; Joseph Aisner; P I Terasaki; P H Wiernik
A study of HLA antigens and haplotypes in a population of Caucasians with acute non-lymphocytic leukemia.
Leukemia research 1979;3(2):75-82.
1979: Charles Alan Schiffer
Filtration leukapheresis: summary and perspectives.
Experimental hematology 1979;7(4 Suppl):42-7.
1979: Joseph Aisner; Charles Alan Schiffer; S Hedmann; P H Wiernik
Gravity leukapheresis--a simple method of leukocyte collection for transfusion or in vitro study.
Leukemia research 1979;3(1):1-5.
1978: Charles Alan Schiffer; Joseph Aisner
Filtration leukapheresis (FL) and granulocytes.
Blood 1978;52(6):1249-50.
1978: Charles Alan Schiffer
The present status of blood component therapy in the United States.
[Rinshō ketsueki] The Japanese journal of clinical hematology 1978;19(10):1467-73.
1978: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Frozen autologous platelet transfusion for patients with leukemia.
The New England journal of medicine 1978;299(1):7-12.
1978: Charles Alan Schiffer
Some aspects of recent advances in the use of blood cell components.
British journal of haematology 1978;39(3):289-94.
1978: Joseph Aisner; Charles Alan Schiffer; P H Wiernik
Granulocyte transfusions: evaluation of factors influencing results and a comparison of filtration and intermittent centrifugation leukapheresis.
British journal of haematology 1978;38(1):121-9.
1978: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Platelet transfusion therapy for patients with leukemia.
Progress in clinical and biological research 1978;28():267-79.
1977: Charles Alan Schiffer; Joseph Aisner
Failure of postfiltration leukapheresis plasma to increase granulocyte yields.
Transfusion 1977;17(5):500-2.
1977: Charles Alan Schiffer
Principles of granulocyte transfusion therapy.
The Medical clinics of North America 1977;61(5):1119-31.
1977: Charles Alan Schiffer; F T Sanel; V B Young; Joseph Aisner
Reversal of granulocyte adherence to nylon fibers using local anesthetic agents: possible application to filtration leukapheresis.
Blood 1977;50(2):213-25.
1977: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Current status of granulocyte transfusion therapy.
Progress in clinical and biological research 1977;13():281-92.
1976: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Clinical experience with transfusion of cryopreserved platelets.
British journal of haematology 1976;34(3):377-85.
1976: Charles Alan Schiffer; H J Weinstein; P H Wiernik
Letter: Methicillin-associated thrombocytopenia.
Annals of internal medicine 1976;85(3):338-9.
1976: Joseph Aisner; Charles Alan Schiffer; J H Wolff; P H Wiernik
A standardized technique for efficient platelet and leukocyte collection using the Model 30 Blood Processor.
Transfusion 1976;16(5):437-45.
1976: Charles Alan Schiffer; C L Whitaker; M Schmukler; Joseph Aisner; S L Hilbert
The effect of dimethyl sulfoxide on in vitro platelet function.
Thrombosis and haemostasis 1976;36(1):221-9.
1976: R J Rubin; Charles Alan Schiffer
Fate in humans of the plasticizer, di-2-ethylhexyl phthalate, arising from transfusion of platelets stored in vinyl plastic bags.
Transfusion 1976;16(4):330-5.
1976: Charles Alan Schiffer; D H Buchholz; Joseph Aisner; J H Wolff; P H Wiernik
Frozen autologous platelets in the supportive care of patients with leukemia.
Transfusion 1976;16(4):321-9.
1976: Charles Alan Schiffer; J L Lichtenfeld; P H Wiernik; M R Mardiney; J M Joseph
Antibody response in patients with acute nonlymphocytic leukemia.
Cancer 1976;37(5):2177-82.
1976: F T Sanel; Joseph Aisner; Charles Alan Schiffer
Letter: Filtration leukopheresis.
Blood 1976;47(5):877-9.
1976: P H Wiernik; Stephen C Schimpff; Charles Alan Schiffer; J L Lichtenfeld; Joseph Aisner; M J O'Connell; C Fortner
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Cancer treatment reports 1976;60(1):41-53.
1975: Charles Alan Schiffer; J A Levi; P H Wiernik
The significance of abnormal circulating cells in patients with Hodgkin's disease.
British journal of haematology 1975;31(2):177-83.
1975: Charles Alan Schiffer; Joseph Aisner; M Schmukler; C L Whitaker; J H Wolff
The effect of hydroxyethyl starch on in vitro platelet and granulocyte function.
Transfusion 1975;15(5):473-5.
1975: Charles Alan Schiffer; F T Sanel; B K Stechmiller; P H Wiernik
Functional and morphologic characteristics of the leukemic cells of a patient with acute monocytic leukemia: correlation with clinical features.
Blood 1975;46(1):17-26.
1975: D H Buchholz; Charles Alan Schiffer; P H Wiernik; S W Betts; J A Reilly
Granulocyte harvest for transfusion: donor response to repeated leukapheresis.
Transfusion 1975;15(2):96-106.
1975: Charles Alan Schiffer; D H Buchholz; Joseph Aisner; S W Betts; P H Wiernik
Clinical experience with transfusion of granulocytes obtained by continuous flow filtration leukopheresis.
The American journal of medicine 1975;58(3):373-81.
1975: Charles Alan Schiffer; Joseph Aisner; P H Wiernik
Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters.
Blood 1975;45(1):141-6.
1974: Charles Alan Schiffer; D H Buchholz; P H Wiernik
Intensive multiunit plateletpheresis of normal donors.
Transfusion 1974;14(4):388-94.